Clinical Trial Readiness for SCA1 and SCA3

Age
18 years - 65 years
Gender
All
participants needed
10
Location
1
Clinical Trial Readiness for SCA1 and SCA3

Brief description of study

The prospective study is to establish the world's largest cohort of premanifest and early-stage SCA1 and SCA3 individuals.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: SCA1 SCA3,SCA1 ,SCA3
  • Age: 18 years - 65 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 833946
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research